{
  "DOI": "10.1038/ejhg.2010.198",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2010.198",
  "alternative-id": [
    "BFejhg2010198"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "McWilliams",
      "given": "Robert R",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Wieben",
      "given": "Eric D",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rabe",
      "given": "Kari G",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pedersen",
      "given": "Katrina S",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wu",
      "given": "Yanhong",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sicotte",
      "given": "Hugues",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Petersen",
      "given": "Gloria M",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2010,
        12,
        8
      ]
    ],
    "date-time": "2010-12-08T14:07:25Z",
    "timestamp": 1291817245000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        6,
        4
      ]
    ],
    "date-time": "2023-06-04T12:18:04Z",
    "timestamp": 1685881084000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        12
      ]
    ],
    "date-time": "2024-04-12T21:19:12Z",
    "timestamp": 1712956752304
  },
  "is-referenced-by-count": 96,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2010,
        12,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2011,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2010,
            12,
            8
          ]
        ],
        "date-time": "2010-12-08T00:00:00Z",
        "timestamp": 1291766400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2010198.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2010198",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2010198.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "472-478",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2010,
        12,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2010,
        12,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "HT Lynch",
      "first-page": "17",
      "journal-title": "Can Med Assoc J",
      "key": "BFejhg2010198_CR1",
      "unstructured": "Lynch HT, Krush AJ : Heredity and malignant melanoma: implications for early cancer detection. Can Med Assoc J 1968; 99: 17–21.",
      "volume": "99",
      "year": "1968"
    },
    {
      "DOI": "10.1056/NEJM199510123331504",
      "author": "AM Goldstein",
      "doi-asserted-by": "publisher",
      "first-page": "970",
      "journal-title": "New Engl J Med",
      "key": "BFejhg2010198_CR2",
      "unstructured": "Goldstein AM, Fraser MC, Struewing JP et al: Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. New Engl J Med 1995; 333: 970–974.",
      "volume": "333",
      "year": "1995"
    },
    {
      "DOI": "10.1097/00000658-200212000-00005",
      "author": "DK Bartsch",
      "doi-asserted-by": "publisher",
      "first-page": "730",
      "journal-title": "Ann Surg",
      "key": "BFejhg2010198_CR3",
      "unstructured": "Bartsch DK, Sina-Frey M, Lang S et al: CDKN2A germline mutations in familial pancreatic cancer. Ann Surg 2002; 236: 730–737.",
      "volume": "236",
      "year": "2002"
    },
    {
      "DOI": "10.1002/cncr.10159",
      "author": "HT Lynch",
      "doi-asserted-by": "publisher",
      "first-page": "84",
      "journal-title": "Cancer",
      "key": "BFejhg2010198_CR4",
      "unstructured": "Lynch HT, Brand RE, Hogg D et al: Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 2002; 94: 84–96.",
      "volume": "94",
      "year": "2002"
    },
    {
      "author": "M Schutte",
      "first-page": "3126",
      "journal-title": "Cancer Res",
      "key": "BFejhg2010198_CR5",
      "unstructured": "Schutte M, Hruban RH, Geradts J et al: Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997; 57: 3126–3130.",
      "volume": "57",
      "year": "1997"
    },
    {
      "author": "F Jing",
      "first-page": "14",
      "journal-title": "Onkologie",
      "key": "BFejhg2010198_CR6",
      "unstructured": "Jing F, Zhang J, Tao J et al: Hypermethylation of tumor suppressor genes BRCA1, p16 and 14–3–3sigma in serum of sporadic breast cancer patients. Onkologie 2007; 30: 14–19.",
      "volume": "30",
      "year": "2007"
    },
    {
      "DOI": "10.1136/jmg.2005.031476",
      "author": "T Debniak",
      "doi-asserted-by": "publisher",
      "first-page": "763",
      "journal-title": "J Med Genet",
      "key": "BFejhg2010198_CR7",
      "unstructured": "Debniak T, Gorski B, Huzarski T et al: A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet 2005; 42: 763–765.",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-0403",
      "author": "FA de Snoo",
      "doi-asserted-by": "publisher",
      "first-page": "7151",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2010198_CR8",
      "unstructured": "de Snoo FA, Bishop DT, Bergman W et al: Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res 2008; 14: 7151–7157.",
      "volume": "14",
      "year": "2008"
    },
    {
      "author": "M Bahuau",
      "first-page": "2298",
      "journal-title": "Cancer Res",
      "key": "BFejhg2010198_CR9",
      "unstructured": "Bahuau M, Vidaud D, Jenkins RB et al: Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 1998; 58: 2298–2303.",
      "volume": "58",
      "year": "1998"
    },
    {
      "DOI": "10.1093/jnci/88.20.1489",
      "author": "WG Yarbrough",
      "doi-asserted-by": "publisher",
      "first-page": "1489",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2010198_CR10",
      "unstructured": "Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET : Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst 1996; 88: 1489–1491.",
      "volume": "88",
      "year": "1996"
    },
    {
      "DOI": "10.1038/375503a0",
      "author": "J Lukas",
      "doi-asserted-by": "publisher",
      "first-page": "503",
      "journal-title": "Nature",
      "key": "BFejhg2010198_CR11",
      "unstructured": "Lukas J, Parry D, Aagaard L et al: Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995; 375: 503–506.",
      "volume": "375",
      "year": "1995"
    },
    {
      "DOI": "10.1097/CEJ.0b013e3282f75eb1",
      "author": "Ta Debniak",
      "doi-asserted-by": "publisher",
      "first-page": "389",
      "journal-title": "Eur J Cancer Prev",
      "key": "BFejhg2010198_CR12",
      "unstructured": "Debniak Ta, van de Wetering Ta, Scott Re et al: Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland. Eur J Cancer Prev 2008; 17: 389–391.",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1093/annonc/mdg498",
      "author": "P Ghiorzo",
      "doi-asserted-by": "publisher",
      "first-page": "70",
      "journal-title": "Ann Oncol",
      "key": "BFejhg2010198_CR13",
      "unstructured": "Ghiorzo P, Pastorino L, Bonelli L et al: INK4/ARF germline alterations in pancreatic cancer patients. Ann Oncol 2004; 15: 70–78.",
      "volume": "15",
      "year": "2004"
    },
    {
      "DOI": "10.1002/1097-0215(20000915)87:6\u003c809::AID-IJC8\u003e3.0.CO;2-U",
      "author": "HFA Vasen",
      "doi-asserted-by": "publisher",
      "first-page": "809",
      "journal-title": "Int J Cancer",
      "key": "BFejhg2010198_CR14",
      "unstructured": "Vasen HFA, Gruis NA, Frants RR, van der Velden PA, Hille ETM, Bergman W : Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000; 87: 809–811.",
      "volume": "87",
      "year": "2000"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-08-1109",
      "author": "RR McWilliams",
      "doi-asserted-by": "publisher",
      "first-page": "1295",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BFejhg2010198_CR15",
      "unstructured": "McWilliams RR, Bamlet WR, de Andrade M, Rider DN, Cunningham JM, Petersen GM : Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiol Biomarkers Prev 2009; 18: 1295–1302.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1093/nar/25.14.2745",
      "author": "DA Nickerson",
      "doi-asserted-by": "publisher",
      "first-page": "2745",
      "journal-title": "Nucleic Acids Res",
      "key": "BFejhg2010198_CR16",
      "unstructured": "Nickerson DA, Tobe VO, Taylor SL : PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997; 25: 2745–2751.",
      "volume": "25",
      "year": "1997"
    },
    {
      "DOI": "10.1002/0471249688",
      "author": "A Agresti",
      "doi-asserted-by": "publisher",
      "key": "BFejhg2010198_CR17",
      "unstructured": "Agresti A : Categorical Data Analysis, 2nd edn, John Wiley \u0026 Sons: Hoboken, NJ, 2002.",
      "volume-title": "Categorical Data Analysis",
      "year": "2002"
    },
    {
      "DOI": "10.1111/j.0006-341X.2001.00245.x",
      "author": "N Chatterjee",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "journal-title": "Biometrics",
      "key": "BFejhg2010198_CR18",
      "unstructured": "Chatterjee N, Wacholder S : A marginal likelihood approach for estimating penetrance from kin-cohort designs. Biometrics 2001; 57: 245–252.",
      "volume": "57",
      "year": "2001"
    },
    {
      "author": "J Hashemi",
      "first-page": "6864",
      "journal-title": "Cancer Res",
      "key": "BFejhg2010198_CR19",
      "unstructured": "Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J : CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Cancer Res 2000; 60: 6864–6867.",
      "volume": "60",
      "year": "2000"
    },
    {
      "DOI": "10.1136/jmg.2007.055376",
      "author": "AM Goldstein",
      "doi-asserted-by": "publisher",
      "first-page": "284",
      "journal-title": "J Med Gen",
      "key": "BFejhg2010198_CR20",
      "unstructured": "Goldstein AM, Stacey SN, Olafsson JH et al: CDKN2A mutations and melanoma risk in the Icelandic population. J Med Gen 2008; 45: 284–289.",
      "volume": "45",
      "year": "2008"
    },
    {
      "DOI": "10.1038/sj.jid.5700293",
      "author": "T Spica",
      "doi-asserted-by": "publisher",
      "first-page": "1657",
      "journal-title": "J Invest Dermatol",
      "key": "BFejhg2010198_CR21",
      "unstructured": "Spica T, Portela M, Gerard B et al: The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. J Invest Dermatol 2006; 126: 1657–1660.",
      "volume": "126",
      "year": "2006"
    },
    {
      "DOI": "10.1038/ng0994-15",
      "author": "CJ Hussussian",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "Nat Genet",
      "key": "BFejhg2010198_CR22",
      "unstructured": "Hussussian CJ, Struewing JP, Goldstein AM et al: Germline p16 mutations in familial melanoma. Nat Genet 1994; 8: 15–21.",
      "volume": "8",
      "year": "1994"
    },
    {
      "DOI": "10.1038/ng0994-22",
      "author": "A Kamb",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Nat Genet",
      "key": "BFejhg2010198_CR23",
      "unstructured": "Kamb A, Shattuck-Eidens D, Eeles R et al: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994; 8: 23–26.",
      "volume": "8",
      "year": "1994"
    },
    {
      "DOI": "10.1097/CMR.0b013e328014a2cd",
      "author": "D Pjanova",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "journal-title": "Melanoma Res",
      "key": "BFejhg2010198_CR24",
      "unstructured": "Pjanova D, Engele L, Randerson-Moor JA et al: CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population. Melanoma Res 2007; 17: 185–191.",
      "volume": "17",
      "year": "2007"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-0494",
      "author": "AM Goldstein",
      "doi-asserted-by": "publisher",
      "first-page": "9818",
      "journal-title": "Cancer Res",
      "key": "BFejhg2010198_CR25",
      "unstructured": "Goldstein AM, Chan M, Harland M et al: High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 2006; 66: 9818–9828.",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1093/jnci/dji312",
      "author": "CB Begg",
      "doi-asserted-by": "publisher",
      "first-page": "1507",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2010198_CR26",
      "unstructured": "Begg CB, Orlow I, Hummer AJ et al: Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005; 97: 1507–1515.",
      "volume": "97",
      "year": "2005"
    },
    {
      "DOI": "10.1200/JCO.2007.13.5624",
      "author": "P Ghiorzo",
      "doi-asserted-by": "publisher",
      "first-page": "5336",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg2010198_CR27",
      "unstructured": "Ghiorzo P, Gargiulo S, Nasti S et al: Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy. J Clin Oncol 2007; 25: 5336–5337.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S1525-1578(10)60667-8",
      "author": "I Orlow",
      "doi-asserted-by": "publisher",
      "first-page": "158",
      "journal-title": "J Mol Diagn",
      "key": "BFejhg2010198_CR28",
      "unstructured": "Orlow I, Roy P, Barz A, Canchola R, Song Y, Berwick M : Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations. J Mol Diagn 2001; 3: 158–163.",
      "volume": "3",
      "year": "2001"
    },
    {
      "DOI": "10.1002/humu.9247",
      "author": "AM Goldstein",
      "doi-asserted-by": "publisher",
      "first-page": "630",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2010198_CR29",
      "unstructured": "Goldstein AM : Familial melanoma, pancreatic cancer and germline CDKN2A mutations. Hum Mutat 2004; 23: 630.",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.onc.1206564",
      "author": "JL Rutter",
      "doi-asserted-by": "publisher",
      "first-page": "4444",
      "journal-title": "Oncogene",
      "key": "BFejhg2010198_CR30",
      "unstructured": "Rutter JL, Goldstein AM, Davila MR, Tucker MA, Struewing JP : CDKN2A point mutations D153spl(c.457G\u0026gt;T) and IVS2+1G\u0026gt;T result in aberrant splice products affecting both p16INK4a and p14ARF. Oncogene 2003; 22: 4444–4448.",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1038/5082",
      "author": "L Liu",
      "doi-asserted-by": "publisher",
      "first-page": "128",
      "journal-title": "Nat Genet",
      "key": "BFejhg2010198_CR31",
      "unstructured": "Liu L, Dilworth D, Gao L et al: Mutation of the CDKN2A 5′ UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet 1999; 21: 128–132.",
      "volume": "21",
      "year": "1999"
    },
    {
      "DOI": "10.1158/0008-5472.835.65.3",
      "author": "T Debniak",
      "doi-asserted-by": "crossref",
      "first-page": "835",
      "journal-title": "Cancer Res",
      "key": "BFejhg2010198_CR32",
      "unstructured": "Debniak T, Scott RJ, Huzarski T et al: CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res 2005; 65: 835–839.",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1002/cncr.10159",
      "author": "HT Lynch",
      "doi-asserted-by": "publisher",
      "first-page": "84",
      "journal-title": "Cancer",
      "key": "BFejhg2010198_CR33",
      "unstructured": "Lynch HT, Brand RE, Hogg D et al: Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 2002; 94: 84–96.",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/92.15.1260",
      "author": "A Borg",
      "doi-asserted-by": "publisher",
      "first-page": "1260",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2010198_CR34",
      "unstructured": "Borg A, Sandberg T, Nilsson K et al: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000; 92: 1260–1266.",
      "volume": "92",
      "year": "2000"
    },
    {
      "DOI": "10.1136/jmg.2004.019349",
      "author": "AM Goldstein",
      "doi-asserted-by": "publisher",
      "first-page": "421",
      "journal-title": "J Med Genet",
      "key": "BFejhg2010198_CR35",
      "unstructured": "Goldstein AM, Struewing JP, Fraser MC, Smith MW, Tucker MA : Prospective risk of cancer in CDKN2A germline mutation carriers. J Med Genet 2004; 41: 421–424.",
      "volume": "41",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.jaad.2009.03.016",
      "author": "Sancy A. Leachman",
      "doi-asserted-by": "publisher",
      "first-page": "677.e1-677.e14",
      "issue": "4",
      "journal-title": "Journal of the American Academy of Dermatology",
      "key": "BFejhg2010198_CR36",
      "unstructured": "Leachman SA, Carucci J, Kohlmann W et al: Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad of Dermatol 2009; 61: 677.e1–677.e14.",
      "volume": "61",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S1470-2045(04)01469-X",
      "author": "CB Hansen",
      "doi-asserted-by": "publisher",
      "first-page": "314",
      "journal-title": "Lancet Oncol",
      "key": "BFejhg2010198_CR37",
      "unstructured": "Hansen CB, Wadge LM, Lowstuter K, Boucher K, Leachman SA : Clinical germline genetic testing for melanoma. Lancet Oncol 2004; 5: 314–319.",
      "volume": "5",
      "year": "2004"
    },
    {
      "author": "M Mantelli",
      "first-page": "214",
      "journal-title": "Am J Med Genet",
      "key": "BFejhg2010198_CR38",
      "unstructured": "Mantelli M, Barile M, Ciotti P et al: High prevalence of the G101W germline mutation in the CDKN2A (P16/ink4a) gene in 62 Italian malignant melanoma families. Am J Med Genet 2002; 107: 214–221.",
      "volume": "107",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/86.20.1510",
      "author": "DT Silverman",
      "doi-asserted-by": "publisher",
      "first-page": "1510",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2010198_CR39",
      "unstructured": "Silverman DT, Dunn JA, Hoover RN et al: Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1994; 86: 1510–1516.",
      "volume": "86",
      "year": "1994"
    },
    {
      "DOI": "10.1001/archinte.1996.00440180119015",
      "author": "CS Fuchs",
      "doi-asserted-by": "publisher",
      "first-page": "2255",
      "journal-title": "Arch Intern Med",
      "key": "BFejhg2010198_CR40",
      "unstructured": "Fuchs CS, Colditz GA, Stampfer MJ et al: A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1996; 156: 2255–2260.",
      "volume": "156",
      "year": "1996"
    }
  ],
  "reference-count": 40,
  "references-count": 40,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2010198"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling"
  ],
  "type": "journal-article",
  "volume": "19"
}